We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-12.85%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$323B
AUM Growth
-$31.4B
Cap. Flow
+$21.9B
Cap. Flow %
6.78%
Top 10 Hldgs %
17.35%
Holding
4,266
New
149
Increased
3,108
Reduced
374
Closed
120

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$1.01B
2
MSFT icon
Microsoft
MSFT
+$761M
3
AAPL icon
Apple
AAPL
+$685M
4
AMZN icon
Amazon
AMZN
+$507M
5
CI icon
Cigna
CI
+$391M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Financials 15.19%
3 Healthcare 14.85%
4 Consumer Discretionary 10.09%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHNR icon
4051
China Natural Resources
CHNR
$5.04M
$18K ﹤0.01%
281
DSS icon
4052
DSS Inc
DSS
$5.52M
$18K ﹤0.01%
46
ELDN icon
4053
Eledon Pharmaceuticals
ELDN
$266M
$18K ﹤0.01%
651
DCOY
4054
Decoy Therapeutics
DCOY
$2.23M
0
FCSC
4055
DELISTED
Fibrocell Science Inc.
FCSC
$18K ﹤0.01%
12,643
HEPA
4056
DELISTED
Hepion Pharmaceuticals
HEPA
$17K ﹤0.01%
1
LTBR icon
4057
Lightbridge
LTBR
$294M
$17K ﹤0.01%
2,716
SNGX icon
4058
Soligenix
SNGX
$5.68M
$17K ﹤0.01%
85
XPL icon
4059
Solitario Resources
XPL
$68.9M
$17K ﹤0.01%
75,942
XWEL icon
4060
XWELL
XWEL
$8.44M
$17K ﹤0.01%
93
ADOM
4061
DELISTED
ADOMANI Inc
ADOM
$17K ﹤0.01%
62,890
-10,693
-15% -$4.78K
ATOS icon
4062
Atossa Therapeutics
ATOS
$23.8M
$16K ﹤0.01%
1,051
CNVS icon
4063
Cineverse
CNVS
$62.8M
$16K ﹤0.01%
1,467
IPWR icon
4064
Ideal Power
IPWR
$68.8M
$16K ﹤0.01%
6,528
VERO
4065
DELISTED
Venus Concept
VERO
$16K ﹤0.01%
15
ORKA
4066
Oruka Therapeutics
ORKA
$5.86B
$16K ﹤0.01%
225
AEY
4067
DELISTED
ADDvantage Technologies Group
AEY
$16K ﹤0.01%
1,193
DTEA
4068
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$16K ﹤0.01%
13,680
STAB
4069
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$16K ﹤0.01%
16,688
IDSA
4070
DELISTED
Industrial Services of America
IDSA
$16K ﹤0.01%
15,157
ARMP icon
4071
Armata Pharmaceuticals
ARMP
$173M
$15K ﹤0.01%
5,208
MLSS icon
4072
Milestone Scientific
MLSS
$41.4M
$15K ﹤0.01%
45,410
SUNW
4073
DELISTED
Sunworks, Inc.
SUNW
$15K ﹤0.01%
8,611
NVIV
4074
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$15K ﹤0.01%
13
GURE
4075
Gulf Resources
GURE
$4.68M
$14K ﹤0.01%
361

Similar funds

Geode Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.

  • Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
  • Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
  • Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
  • Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
  • Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
  • Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
  • Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.

Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.